M. Finnegan

Elevated levels of MDM-2 and p53 expression are associated with high grade non-Hodgkin's lymphomas.

J. Royds, J. Goepel, B. Hancock, 1994, Cancer letters.

Regulation of cellular sphingosine-1-phosphate by sphingosine kinase 1 and sphingosine-1-phopshate lyase determines chemotherapy resistance in gastroesophageal cancer

H. Grabsch, P. Tan, G. Murray, 2015, BMC Cancer.

Analysis of the p53 gene, its expression and protein stabilization in non-Hodgkin's lymphomas.

K. A. Lee, J. Royds, E. Sheridan, 1994, Annals of oncology : official journal of the European Society for Medical Oncology.

Activation of MYCN in a case of non-Hodgkin's lymphoma.

B. Hancock, M. Goyns, D. Hammond, 1995, Leukemia & lymphoma.

Variable expression of the interleukin-2 receptor alpha chain and MYC genes in lymphocytes from renal cell carcinoma patients treated with interleukin-2.

K. A. Lee, R. Rees, K. Hayat, 1992, Cancer letters.

MDR-1 expression in non-Hodgkin's lymphomas is unrelated to treatment intensity or response to therapy.

P. Lorigan, J. Royds, J. Goepel, 1995, Leukemia & lymphoma.

Investigation of the expression of housekeeping genes in non-Hodgkin's lymphoma.

J. Goepel, B. Hancock, M. Goyns, 1993, Leukemia & lymphoma.